Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Welocalize Achieves ISO 18587 Certification for Human Post-Edited Machine Translation Services

Life sciences companies looking to decrease time-to-market and translation costs, without reducing quality, benefit from ISO-certified PEMT solutions



FREDERICK, Md. - September 15, 2020 - (Newswire.com)

​Welocalize Life Sciences announces its US-based operations has achieved ISO 18587:2017 certification, which provides requirements for the process of full, human post-editing of machine translation (PEMT) output and post-editors' competences. This certification is the latest in the language services provider’s continued compliance. Welocalize also holds ISO 9001:2015 (Quality Management), ISO 17100:2015 (Translation Services), and ISO 13485:2016 (Medical Devices) certifications.

Requirements of ISO 18587 include standards related to post-processing quality control of raw MT output. It also outlines mandatory competencies of review and quality control personnel to ensure that risk associated with MT content is adequately managed.

Welocalize offers AI-enabled translation services and has developed custom, trained engines for a wide-range of industries, including life sciences.

Adds Olga Beregovaya, Welocalize’s VP Language Services, “After more than a decade of training a specific MT engine tailored for clinical trial documentation, Welocalize Life Sciences’ clients are seeing incredible results. Specifically, the integration of MT solutions can lead to greater cost savings and faster market entry, making valuable therapies and devices available to patients sooner.”

The company’s certification to ISO 18587 underscores its commitment to guaranteeing best practices are employed at all times with respect to AI-enabled translation, and that content is thoroughly vetted by qualified resources to ensure high-quality output that improves over time.

“The importance of this certification is that our clients can feel confident about the quality of the machine-translated content. In an industry where translation quality is critical for drug and device approval, we understand how important this, and other certifications are, to obtain and maintain,” comments Silvie Peric, Director of Quality Systems & Strategy, Welocalize.

Life sciences companies looking to decrease time-to-market and translation costs, without reducing quality, benefit from MT solutions. The important thing is to find a language services provider with access to a range of quality solutions, including ISO-certified PEMT.

About Welocalize Life Sciences, a Welocalize company

Welocalize, Inc., founded in 1997, offers innovative language services to help global brands reach audiences around the world in more than 250 languages. The company provides translation and localization services, talent management, language tools, automation and technology, quality, and program management. Its range of managed language services include machine translation, digital marketing, validation and testing, interpreting, staffing, and enterprise translation management technologies. Welocalize Life Sciences specializes in language services for highly regulated sectors including clinical research, pharmaceutical, biotechnology, healthcare, medical devices, and animal health. welocalize.com




Press Release Service by Newswire.com

Original Source: Welocalize Achieves ISO 18587 Certification for Human Post-Edited Machine Translation Services
Latest News
Top News